Drug Prices, Foreign Exchange Volatility and New Tax Rules: A 2026 compliance strategy guide for Nigeria’s pharmaceutical sector 

SBP 3 use

Nigeria’s macroeconomic outlook for 2026 presents cautious optimism. Headline inflation moderated to 15.10% in January 2026, with the National Bureau

read more Drug Prices, Foreign Exchange Volatility and New Tax Rules: A 2026 compliance strategy guide for Nigeria’s pharmaceutical sector

   

Leave a Reply

Your email address will not be published. Required fields are marked *